Schedule 13G ownership disclosure

KalVista Pharmaceuticals Inc

Security class unavailable · CUSIP: 483497103

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,419,792
Percent of class
3.2900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-24-006397
Form type
SC 13G/A
Filer
Adage Capital Management, L.P.
CIK
CIK 1535978
Filed
Nov 12, 2024
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub